Search

PHOTO: Dr. Robert Vanner (left) and Dr. Sheila Singh, recipients of the 2025 Translational Research Grants in Brain Cancer. Brain Canada and Cancer Research Society (CRS) are advancing brain cancer research through collaborative innovation and translational impact As part of their ongoing...

The Histology Innovation Platform at McGill University is a specialized facility that helps scientists study the brain at a cellular level to better understand neurological diseases like Alzheimer’s, brain cancer, and epilepsy. Project Overview The Histology Innovation Platform at McGill...

Saskatchewan Health Research Foundation (SHRF), Brain Canada, Jim Pattison Children’s Hospital Foundation (JPCHF), Alzheimer Society of Saskatchewan (ASOS) and Lung Saskatchewan are proud to share that we’re investing $2.7 million in peer-reviewed, home-grown research solutions addressing...

Opioid use disorder (OUD) incurs staggering harm to individuals, families, healthcare systems, and society. In Ontario (2020), opioids drove 2415 deaths and costs of $2.73 billion. Unfortunately, treatments are severely limited, with a ~70% relapse rate. An untapped approach is deep brain...

Group of cells expressing mutant huntingtin (in red) in vitro. Yellow puncta are aggregates of mutant huntingtin and p62, a protein involved in the clearance of protein aggregates. Huntington disease (HD) is an inherited disorder that causes progressive malfunctioning and death of parts of the...

Annually, approximately 250,000 people in Canada sustain a concussion. Project Overview Annually, approximately 250,000 people in Canada sustain a concussion. While symptoms following concussion generally improve within 3 months, up to 30% of people continue to have symptoms beyond this time....

PHOTO: From Left: Dr. Aristotle Voineskos (CAMH), Sarah Downey (CAMH), Dr. Viviane Poupon (Brain Canada), Dr. Tristan Glatard (CAMH), and Dr. Ali Khan (Western) in Toronto. (CNW Group/Brain Canada) Two cutting-edge platforms at CAMH and Western University aim to accelerate AI-driven brain...

An AI-powered smart-phone app that enables doctors to monitor their patients’ symptoms, and their response to medication between appointments, shows promise as a new tool in the treatment of depression and anxiety, according to a recent research study. Smartphone app boosts communication between...

We are testing a new digital mental health solution for physicians to better manage the treatment of depression. Project Overview We are testing a new digital mental health solution for physicians to better manage the treatment of depression. While many treatment options for depression are...

Medical Assistance in Dying (MAiD) was legalized in June 2016 in Canada and now allows patients suffering from a “grievous and irremediable medical condition” like amyotrophic lateral sclerosis (ALS) to access another end-of-life treatment option. Project Overview Medical Assistance in Dying...